chr3-150972700-G-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2
The NM_174878.3(CLRN1):c.9C>A(p.Ser3Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,614,218 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_174878.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLRN1 | NM_174878.3 | c.9C>A | p.Ser3Arg | missense_variant | 1/3 | ENST00000327047.6 | NP_777367.1 | |
CLRN1-AS1 | NR_024066.2 | n.23G>T | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLRN1 | ENST00000327047.6 | c.9C>A | p.Ser3Arg | missense_variant | 1/3 | 1 | NM_174878.3 | ENSP00000322280 | P1 | |
ENST00000469268.1 | n.236-28874G>T | intron_variant, non_coding_transcript_variant | 4 | |||||||
CLRN1-AS1 | ENST00000476886.5 | n.124-90226G>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000617 AC: 155AN: 251058Hom.: 1 AF XY: 0.000619 AC XY: 84AN XY: 135712
GnomAD4 exome AF: 0.000251 AC: 367AN: 1461886Hom.: 2 Cov.: 32 AF XY: 0.000257 AC XY: 187AN XY: 727244
GnomAD4 genome AF: 0.000282 AC: 43AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000322 AC XY: 24AN XY: 74502
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 08, 2016 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 18, 2016 | p.Ser3Arg in exon 1 of CLRN1: This variant is not expected to have clinical sign ificance because it has been identified in 0.8% (73/8624) of East Asian chromoso mes Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP s1 87218889). - |
Usher syndrome type 3A Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 13, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at